Aclarion Will Present at LD Micro Event in October
The medical diagnostics firm will outline its Nociscan platform at the 20th annual LD Micro Main Event.
Updated on Oct. 13, 2026 in Industry — General
Live Poll
Do you generally trust presentations made by small-cap companies at investor conferences?
Healthcare technology company Aclarion is scheduled to present at the 20th annual LD Micro Main Event in Los Angeles on October 20, 2026. The conference, held at the Luxe Sunset Boulevard Hotel, will feature presentations from more than 100 public companies.
Why it matters
The event provides a platform for mid-market and smaller public companies to detail their growth strategies and operational outlooks to a broad investment audience. For operators, such presentations serve as a proxy for the capital-raising climate and current development priorities within the healthcare technology sector.
The 20th annual LD Micro Main Event will feature over 100 public companies, serving as a significant industry gathering. Aclarion, a Broomfield-based firm, expects to maintain its current cash runway into the second half of 2027 while preparing an interim data readout for 2026.
The players
Aclarion
A healthcare technology company that produces the Nociscan SaaS platform for low back pain diagnosis.
Brent Ness
The CEO of Aclarion who will present the company's operational progress and projections.
LD Micro
A subsidiary of Freedom US Markets founded in 2006 that organizes investment-focused corporate events.
The details
Aclarion operates the Nociscan SaaS platform, which is designed to aid in the diagnosis of low back pain. During the scheduled session at 11:30 AM PT on October 20, the company is expected to provide operational updates. The event itself runs from October 19 through October 21 at the Luxe Sunset Boulevard Hotel, with individual company presentations occurring throughout the day.
Timeline
October 19, 2026: LD Micro Main Event registration begins.
October 20, 2026: Aclarion presentation at 11:30 AM PT.
October 21, 2026: LD Micro Main Event concludes.
Market Landscape
The 20th Annual LD Micro Main Event follows a long-standing trend of boutique financial conferences serving as primary marketing venues for emerging growth companies. This gathering reflects the broader practice of public firms using specialized investor forums to maintain visibility during their development cycles.
Owners and managers should monitor the upcoming data readout from Aclarion as a benchmark for diagnostic SaaS adoption and R&D progress in the medical space. Keep an eye on the liquidity and runway projections shared during the conference as a proxy for capital markets sentiment toward smaller tech firms.
The takeaway
Investment conferences like LD Micro remain a vital signal for assessing how small-cap entities navigate their cash runways and operational milestones. Watch for the forthcoming 2026 interim data readout from Aclarion as a gauge for product validation in the diagnostic sector.
Further reading
For broader trends in industry conferences and corporate strategy, visit /business/industry/industry-general/.
More information
To register for the conference or review the full list of participating firms, visit LD Micro Main Event registration.
Source note: This article includes information reported by The Manila times.
Live Poll
Do you generally trust presentations made by small-cap companies at investor conferences?
